In April 2018, Joscha Bach met Nectome's CEO and reported to Epstein: "I don't believe that they have a meaningful shot at reviving people, but then, nobody really does." He positioned Nectome against Alcor in the brain preservation market. Sam Altman had reportedly paid $10,000 for Nectome's waiting list.
Marvin Minsky served on Alcor's scientific advisory board and had his brain preserved there after his January 2016 death. Bach framed cryonics as paying "$500 a month for a 1% chance of immortality — seems like a bargain." Associates joked about preserving Epstein's brain: "the hardest brain to cryopreserve because going so fast always it must overheat!!"
Email documenting hidden camera purchase from Fort Lauderdale Spy Store
